Page last updated: 2024-08-21

pyrazines and Liver Diseases, Alcoholic

pyrazines has been researched along with Liver Diseases, Alcoholic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bao, X; Ge, T; Jiang, Y; Jin, H; Lu, C; Shao, Y; Shi, W; Wang, X; Wu, R; Xu, W; Yue, C; Zhou, Y1
Chen, L; Chen, Q; Jin, H; Lu, C; Lu, Y; Shao, J; Wu, L; Xu, W; Zhang, F; Zheng, S1
Bardag-Gorce, F; French, BA; French, SW; Li, J; Lin, A; Oliva, J1
Bardag-Gorce, F1
Bardag-Gorce, F; French, SW; Li, J; Nan, L; Riley, N; Vu, J1

Other Studies

5 other study(ies) available for pyrazines and Liver Diseases, Alcoholic

ArticleYear
Activation of UQCRC2-dependent mitophagy by tetramethylpyrazine inhibits MLKL-mediated hepatocyte necroptosis in alcoholic liver disease.
    Free radical biology & medicine, 2022, 02-01, Volume: 179

    Topics: Electron Transport Complex III; Hepatocytes; Humans; Liver Diseases, Alcoholic; Mitophagy; Necroptosis; Protein Kinases; Pyrazines

2022
Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress.
    International immunopharmacology, 2015, Volume: 29, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Fatty Liver; Liver Diseases, Alcoholic; Male; Oxidative Stress; Pyrazines; Rats; Rats, Sprague-Dawley

2015
Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease.
    Experimental and molecular pathology, 2011, Volume: 90, Issue:1

    Topics: Animals; Boronic Acids; Bortezomib; Cytochrome P-450 CYP2E1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Glutamate-Cysteine Ligase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Synthase; Liver; Liver Diseases, Alcoholic; Male; Oxidative Stress; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors; Up-Regulation

2011
Proteasome inhibitor treatment in alcoholic liver disease.
    World journal of gastroenterology, 2011, May-28, Volume: 17, Issue:20

    Topics: Animals; Boronic Acids; Bortezomib; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Humans; Liver Diseases, Alcoholic; Oxidative Stress; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Rats; Reactive Oxygen Species

2011
Proteasome inhibition induces cytokeratin accumulation in vivo.
    Experimental and molecular pathology, 2004, Volume: 76, Issue:2

    Topics: Alcoholism; Animals; Blotting, Western; Boronic Acids; Bortezomib; Cells, Cultured; Cysteine Endopeptidases; Heat-Shock Proteins; Hepatocytes; Keratins; Liver; Liver Diseases, Alcoholic; Male; Mice; Multienzyme Complexes; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Rats

2004